A much-investigated question about autism, dismissed in many studies, is getting a surge of new federal research money.

In today's Morning Rounds newsletter, NIH is finally spending down its coffers, FDA eyes tighter regulations on chatbots for ...

He relayed the message Tuesday at a meeting of health care product makers and Wednesday to an FDA advocacy group. In addition ...

If Kennedy doesn’t resign, physicians should join a limited strike. Desperate diseases call for desperate measures.

Call it death by disclosure. After nearly 30 years in which prescription drug ads have become a fixture on television, the ...

"The Pitt," nominated for 13 Emmys, ignores the financial consequences of emergency care. The average ED visit costs $750, ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall ...